GFL Ltd

- No specific mention of any current or immediate new fundraising through debt or equity in the call. - Focus is on utilizing existing capacities and completing ongoing CAPEX; no new major CAPEX planned in the next 6 to 12 months. - Debt position: Standalone net debt is virtually zero, and consolidated net debt is about ₹1,200 crores. - Management plans to leverage captive power generation improvements to reduce costs rather than raising funds. - Further expansion CAPEX is planned after stabilizing current investments, but no fundraising details provided. - Demerger process is ongoing, but no related fundraising discussed. - Overall, the company is concentrating on profitability and utilization over new fund raising at this point.

- FY19 CAPEX spent was about Rs 330 crores. - FY19 guidance was around Rs 150 crores more to complete ongoing projects in Specialty Fluoropolymers and Specialty Fluorochemicals. - Focus for next 6-12 months is on fully utilizing existing Fluoropolymers and Fluorochemicals capacities to enhance revenue and profitability. - Blueprint ready for future expansions, but no major CAPEX planned in near term (FY20) as priority is revenue generation and profitability from current investments. - Investments underway include Fluoro Specialty Chemicals plant (~Rs150 crores) with commissioning of products ongoing; full capacity expected by September. - Evaluating opportunities to increase captive power generation, including wind power investments, to reduce power and fuel costs.

- PTFE capacity expanded to about 1700-1800 tonnes per month; current utilization at 1350-1400 tonnes, with plans to reach full capacity (approx. 1800-2000 tonnes) within the next 12 months, driving volume growth. - New Fluoropolymer products (PFA, FEP, PVDF, FKM, Micropowders) in qualification stage expected to add significantly to revenues and profitability in next 12 months. - Fluoro Specialty Chemicals plant (Rs 150 crore investment) targeting commissioning of products by May-June, full capacity by September FY20, expecting 3X asset turns. - Fluorspar Morocco plant targeted for full capacity utilization in 3-4 months (June-July), currently at 40-50%. - Continued emphasis on higher value-added products with price improvement. - Overall, steady revenue and volume growth expected driven by capacity expansions, new product launches, and operational improvements over FY20 and beyond.

- PTFE capacity increased to 1700-1800 tonnes/month with potential to reach full utilization over the next year, driving revenue growth. - New fluoropolymer capacities (PFA, FEP, PVDF, FKM, micropowders) are in commercialization/qualification stages, expected to add significantly to revenues and profits within 12 months. - Chemical segment revenues and profitability have shown strong growth, indicating continued upward momentum. - Wind Turbine segment profitability has improved with growth expected from new generation multi-megawatt turbines. - Implementation of captive power generation projects (e.g., wind) expected to reduce power costs and improve margins. - Management anticipates sustained growth in chemical business revenue and profitability over FY20 and FY21, building on strong FY19 base. - Overall, focused on expanding capacity, enhancing product mix towards value-added grades, and operational efficiency to drive earnings growth.

The transcript provided does not explicitly mention the current or expected order book or pending orders for Gujarat Fluorochemicals Limited. However, relevant insights include: - The Wind Turbine manufacturing business is in an advanced stage of launching a new generation multi-megawatt wind turbine, indicating activity in the order pipeline. - PTFE capacity expansion to 1700-1800 tonnes per month, with a current utilization near 80-85%, implies expectations for increased demand and orders in the coming year. - Fluoro Specialty Chemicals plant commissioning phases scheduled by mid-2019 suggest anticipated order fulfillment and revenue growth. - No specific numerical data on the order book or pending orders is provided in the transcript. For precise current or expected order book details, one would typically refer to a more detailed company report or investor presentation.